Banner Image

Test Directory

Cholinesterase, RBC and Plasma

Test Summary

True cholinesterase (RBC and plasma) activity is decreased in individuals with exposure to organophosphorous insecticides. True cholinesterase, found in erythrocytes and nerve tissue, is responsible for inactivating acetylcholinesterase at nerve endings. With decreased enzyme activity, patients may display a range of nervous system dysfunction. Analysis of RBC and serum or plasma activity is useful in monitoring exposure and recovery.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

5 mL whole blood collected in an EDTA (lavender-top) and
1 mL plasma collected in an EDTA (lavender-top)

Minimum Volume

4 mL whole blood • 0.5 mL plasma

Instructions

Draw two EDTA (lavender-top) tubes of whole blood. Spin one tube to separate plasma. Pour plasma into plastic aliquot tube (label this vial as plasma).

Send one 5 mL refrigerated uncentrifuged whole blood (4 mL minimum) and 1 mL refrigerated plasma (0.5 mL minimum).

Do not send packed cells. Do not send only one tube of whole blood.

Plasma cholinesterase results, as well as the calculated RBC cholinesterase results, are not accurate if plasma sample is not separated from the RBC's in a timely manner.

Hemolyzed plasma samples are not acceptable. Hemolysis can lead to apparent increases in plasma cholinesterase activity, and could mask an enzyme deficiency.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

  • Room temperature: 24 hours
  • Refrigerated: 7 days
  • Frozen: Unacceptable

Limitations

Elevated RBC values, caused by the presence of young RBCs and reticulocytes, may mask acetylcholinesterase inhibition. Plasma results may be depressed in patients who consume oral contraceptives. Hepatic disease may cause up to a 70% decrease in enzyme levels. Cholinesterase may be slightly elevated in patients with obesity or diabetes.

Other Acceptable Specimens

none

Unacceptable Specimens

Hemolysis

Order Code

CHOLRP

EPIC (Premier) Code

LAB3449

Includes

N/A

CPT Code

  • 82480
  • 82482

Billing Code

  • 670186
  • 670187

CPT Statement

Methodology

Kinetic Spectrophotometry (KS)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153

Department

Reference Testing

Reference Range

Cholinesterase, RBC 9572-15031 IU/L
Cholinesterase, Plasma  
  Male 3334-7031 IU/L
  Female 2504-6297 IU/L

Setup Schedule / Expected Turnaround Time

Tuesday - Saturday; Report available: 1 day

Specimen Collection

Special Instructions

N/A

Preferred Specimen

5 mL whole blood collected in an EDTA (lavender-top) and
1 mL plasma collected in an EDTA (lavender-top)

Minimum Volume

4 mL whole blood • 0.5 mL plasma

Instructions

Draw two EDTA (lavender-top) tubes of whole blood. Spin one tube to separate plasma. Pour plasma into plastic aliquot tube (label this vial as plasma).

Send one 5 mL refrigerated uncentrifuged whole blood (4 mL minimum) and 1 mL refrigerated plasma (0.5 mL minimum).

Do not send packed cells. Do not send only one tube of whole blood.

Plasma cholinesterase results, as well as the calculated RBC cholinesterase results, are not accurate if plasma sample is not separated from the RBC's in a timely manner.

Hemolyzed plasma samples are not acceptable. Hemolysis can lead to apparent increases in plasma cholinesterase activity, and could mask an enzyme deficiency.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

  • Room temperature: 24 hours
  • Refrigerated: 7 days
  • Frozen: Unacceptable

Limitations

Elevated RBC values, caused by the presence of young RBCs and reticulocytes, may mask acetylcholinesterase inhibition. Plasma results may be depressed in patients who consume oral contraceptives. Hepatic disease may cause up to a 70% decrease in enzyme levels. Cholinesterase may be slightly elevated in patients with obesity or diabetes.

Other Acceptable Specimens

none

Unacceptable Specimens

Hemolysis

Billing

CPT Code

  • 82480
  • 82482

Billing Code

  • 670186
  • 670187

CPT Statement

Result Information

Methodology

Kinetic Spectrophotometry (KS)

Testing Laboratory

N/A

Reference Range

Cholinesterase, RBC 9572-15031 IU/L
Cholinesterase, Plasma  
  Male 3334-7031 IU/L
  Female 2504-6297 IU/L

Setup Schedule / Expected Turnaround Time

Tuesday - Saturday; Report available: 1 day